Status:
COMPLETED
Clinical Effect of MiboFlo in Dry Eye Patients
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Dry Eye Syndromes
Meibomian Gland Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this prospective study is to compare the changes between the patients receiving traditional treatment and the patients with MiBoFlo, evaluating the effectiveness of MiBoFlo.
Detailed Description
The MiBoFlo Thermoflo uses a proprietary thermoelectric heat pump to help meibum maximize liquefaction, improving the preservation and function of the tear film's evaporative component. It supplies co...
Eligibility Criteria
Inclusion
- 18 years of age of older;
- Meet the diagnostic criteria for dry eye developed by DEWS II: OSDI score≥15 points, TBUT≤10 minutes;
- Meet the signs of meibomian gland dysfunction
Exclusion
- Had skin allergies or inflammation;
- Had active ocular infection or inflammation;
- Had history of ocular surgery, eyelid surgery or neurological paralysis within 6 months;
- Had history of systemic disease affecting ocular surface function, such as Stevens-Johnson syndrome, Sjögren syndrome etc.
Key Trial Info
Start Date :
April 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04310969
Start Date
April 3 2020
End Date
June 30 2020
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tongren Hospital
Beijing, Beijing Municipality, China, 100010